Physician profile
Sean E Delaney
NPI 1174557110
$3,978.80
in general payments reported to CMS, 2019-2025
27 companies · $725 in 2025
The $725 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $372 · 2021: $226 · 2022: $265 · 2023: $1,106 · 2024: $1,010 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,840.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $1,179.05 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $411.35 | 2019-2024 | Cardiomems, Mitraclip |
| Amgen INC. | $390.70 | 2020-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $308.89 | 2023-2025 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.55 | 2019-2020 | |
| Angiodynamics, INC. | $151.14 | 2025 | Alphavac |
| Novartis Pharmaceuticals Corporation | $149.00 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $131.61 | 2020-2021 | |
| Esperion Therapeutics, INC. | $126.91 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.46 | 2020-2022 | |
| United Therapeutics Corporation | $122.45 | 2025 | |
| Kestra Medical Technology Services, INC. | $112.98 | 2024 | Assure Wcd |
| Novo Nordisk INC | $107.81 | 2021-2025 | Wegovy |
| Edwards Lifesciences Corporation | $87.62 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $71.69 | 2023-2024 | Uptravi, Opsumit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $59.48 | 2024-2025 | Impella |
| Cvrx, INC. | $38.40 | 2023-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $34.49 | 2019 | |
| Cardiva Medical, INC. | $21.85 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals International, Plc | $21.00 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $19.96 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.32 | 2020 | |
| Ekos Corporation | $16.92 | 2019 | |
| Inari Medical, INC. | $16.35 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $16.28 | 2024 | |
| Pfizer INC. | $12.73 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Delaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.